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Antibiotic resistance has been identified by both the Center for Disease Control and the 
World Health Organization as a worldwide epidemic.  Antimicrobial stewardship 
programs have been utilized at inpatient settings that include educational programs about 
antibiotic resistance.  A systematic review was conducted to evaluate the effectiveness of 
antimicrobial resistance education in outpatient settings.  The databases searched were 
MEDLINE, PubMed, Google Scholar and CINAHL.  PRISMA checklist and flow 
diagram were used for identifying the randomized control trials for the systematic review.  
A total of five articles were identified and organized using data collection tables. The 
Critical Appraisal Skills Programme (CASP) checklist was used to assess the quality of 
the trials.  All five of the articles showed improvement in overall antibiotic prescribing 
with education in an outpatient setting.  Limitations to the studies included 
patient/provider drop-out rates, changing diagnoses to order antibiotics, lack of inclusion 
of all antibiotics ordered by practices, time of year the studies took place, and provider 
access to training regardless of being in sample.  Implications for advanced practice 
nursing were identified as education, starting antibiotic research, utilizing APRN in 
research and leadership were discussed.  Further research is indicated in the effectiveness 
of outpatient teaching to reduce antibiotic resistance as well as other areas of research the 
antimicrobial stewardship programs are utilizing in the inpatient settings.  
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A SYSTEMATIC REVIEW TO EXAMINE THE EFFECTIVENESS OF ANTIBIOTIC  
EDUCATIONAL PROGRAMS IN OUTPATIENT SETTINGS AT REDUCING  
ANTIBIOTIC PRESCRIBING? 
Background/Statement of the Problem 
According to the Center for Disease Control and Prevention (CDC; 2020), the 
United States has over 35,000 deaths and over 2 million illnesses per year due to 
antibiotic resistance.  Antibiotic resistance is when bacteria are able to defeat and 
continue to replicate despite antibiotic treatment.  The CDC recommends four ways to 
reduce antimicrobial resistance (AMR): better lab diagnostics to improve antibiotic 
prescribing, sharing of data amongst countries, better infection control measures and the 
appropriate use of antibiotics.  The Center of Disease Control (2020) appropriate use of 
antibiotics includes the overuse and prescribing of antibiotics.  
The World Health Organization (WHO; 2018) also identified AMR as a 
worldwide epidemic.  The WHO noted further research into bacterial identification is 
needed to target specific microbials.  Bacterial identification is when a sample is taken 
and studied to determine the type of bacteria causing infection.  Bacterial identification is 
required to increase the effectiveness of antibiotics.  The WHO and CDC acknowledge 
the need for stricter regulations on antibiotic prescribing.  Both organizations believe 
implementation of antimicrobial stewardship programs (ASP) will help to fight the 
epidemic of antibiotic resistance in inpatient setting.  Antimicrobial stewardship 
programs consist of teams of infectious disease medical professionals and pharmacists to 
ensure the proper antibiotic treatments.  The ASP also creates educational tools for 
providers to enhance appropriate antibiotic prescribing practices (WHO, 2018).  
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The CDC (2015) found programs dedicated to improving antibiotic use like the 
ASPs optimize the treatment of infections and reduce adverse events associated with 
antibiotic use.  The CDC (2019) found prevention efforts have reduced deaths from 
antibiotic-resistant infections by 18 percent overall and by nearly 30 percent in hospital 
settings.  The CDC and WHO describe the amount of antibiotics unnecessarily prescribed 
is the leading reason for an epidemic of antibiotic resistance.  Ventola (2015) 
demonstrated there is a relationship between antibiotic consumption and the emergence 
of resistant bacterial strains.   
Outpatient settings do not have teams of infectious disease medical professionals 
and pharmacists to ensure the proper antibiotic treatments like inpatient settings.  Most 
outpatient settings are offices with  specific type of providers like primary care, cardiac 
or infectious disease.  The inpatient settings can have infectious disease providers run 
audits on the prescribed antibiotics for all patients in that setting to focus training on. 
Education is one of the most important tools for fighting the current antibiotic resistance 
problem that faces the world today.  The question remains would using these antibiotic 










 While conducting a review of literature the following databases were searched: 
MEDLINE, PubMed, and Google Scholar.  The search terms used to identify literature 
included antibiotic development, antibiotic resistance, antibiotic method of action, 
inpatient and outpatient Antimicrobial Stewardship Program (ASP), antibiotic resistant 
bacterial infections, outpatient bacterial infections and reduced antibiotic prescribing. 
Development of Antibiotics 
 Antibiotic development is associated with Paul Ehrlich and Alexander Fleming.  
Aminov (2010) described how antibiotic use can be traced back to ancient times.  Natural 
traces of tetracycline were found in human skeletal remains and is explained by ancient 
diets high in tetracycline-containing materials.  Paul Ehrlich observed that synthetic dyes 
could stain certain microbes and not others.  From this observation he concluded that 
chemical compounds could be synthesized that would target specific microbes.  In 1904, 
he began a systematic screening program to find a drug to treat syphilis.  Syphilis was 
usually treated with inorganic mercury salts but Ehrlich and others developed a 
compound in 1909, Atoxyl, that first cured syphilis in rabbits.  Later they developed 
Salvarsan, which was used in human trials and was a great success.  Finally, 
Neosalvarsan was developed until it was replaced by penicillin in the 1940s.  The 
systematic screening process for bacterial identification became the cornerstone for 
matching antibiotics drugs to susceptible microbes for the pharmaceutical industry. 
  Alexander Fleming is credited with discovering penicillin on September 3, 1928. 
He observed mold that grew on a culture had caused bacteria to die.  Others had 
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previously made similar observations but Fleming was persistent.  He then requested 
assistance with purification and stability of the active substance and supplied the 
Penicillium strain to anyone requesting it.  An Oxford team led by Howard Florey and 
Ernest Chain published a paper about purification of penicillin, which eventually led to 
penicillin mass production and distribution in 1945.  Even early on Fleming cautioned 
about resistance to penicillin if used improperly (Aminov, 2010). 
Mechanism of Action of Antibiotics  
 Antibiotics are used to treat bacterial infections by causing bacterial cell death.  
The antibiotic induces cell death by inhibiting essential cellular functions of the bacteria.  
Antibiotics can be classified by the system they affect and whether they cause cell death 
(bactericidal drugs) or inhibit the cell growth (bacteriostatic drugs).  Most antibiotics 
either inhibit DNA/RNA synthesis, cell wall synthesis or protein synthesis.  
Understanding the multilayered mechanisms that kill bacteria is important because of the 
increased prevalence of AMR bacteria (Kohanski, Dwyer, & Collins, 2010). 
Kohanski et al. (2010) explains bacterial cell death occurs when the formation of 
double stranded DNA is broken due to the introduction of DNA gyrase inhibitors or the 
arrest of RNA synthesis with treatment.  Bacterial cell wall damage and loss of structural 
integrity is caused by treatments with cell-wall synthesis inhibitors.  Bacterial death from 
protein synthesis is treated with protein synthesis inhibitors. 
Antibiotic Classification 
Antibiotics are classified in several manners.  The most common classification is 
based on their molecular structure or their mode of action.  Other classifications include 
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route of administration (injectable, oral, and topical).  Antibiotics within the same 
structural class usually show similar effectiveness and toxicity but also share similar side 
effects.  The first group of antibiotics are beta-lactams, they interfere with proteins 
needed for synthesis of bacterial cell wall and in the process either kills or inhibits their 
growth.  These beta-lactam antibiotics include penicillin, cephalosporins, monobactams 
and carbapenems (Etebu & Arikekpar, 2016).   
Macrolides, like azithromycin, clarithromycin etc., either kill or inhibit 
microorganisms by inhibiting protein synthesis.  They bind to bacterial ribosome and 
prevent the addition of amino acid to polypeptide chains during protein synthesis.  
Quinolones were first discovered as nalidixic acid while in search of antimalarial drugs.  
These antibiotics interfere with DNA replication and transcription in bacteria.  Common 
quinolones are cinoxacin, norfloxacin, ciproxacin, temafloxacin and others.  
Aminoglycosides are broad spectrum antibiotics and inhibit protein synthesis by binding 
to one of the ribosomal subunits.  Streptomycin is an aminoglycoside used to treat 
Mycobacterium tuberculosis (Etebu and Arikekpar, 2016).   
Sulfonamides, like trimethoprim and sulfamethoxazole, are generally thought to 
be bacteriostatic, but they may become bactericidal if the concentration is high enough or 
if used in the presence of environmental conditions unfavorable to bacteria.  
Glycopeptide antibiotics, like vancomycin, act primarily by inhibiting cell wall synthesis 
of bacteria.  Oxazolidinones antibiotics mechanism of action is not yet fully understood; 




Complications of Antibiotics 
 Antibiotics have common side effects, which cause minor to severe health 
problems (Anderson, 2019).  The side effects are caused by a hypersensitivity to the 
antibiotic medication.  The minor side effects include rash, dizziness, nausea, diarrhea 
and yeast infections.  Minor side effects are usually short term and will usually resolve 
with completion of the antibiotics or switching the prescribed antibiotic.  Yeast 
infections, oral thrush, and diarrhea can be associated with the loss of normal bacteria and 
flora due to antibiotic use.   
 More severe hypersensitivity to antibiotics include allergic reactions, Clostridium 
difficile infection, and severe stomach cramps.  These side effects usually lead to 
emergency room visits.  Anaphylactic reactions are severe hypersensitivity reactions, 
which include shortness of breath, wheezing, severe nausea/vomiting, lightheadedness, 
dizziness, rapid heart rate, swelling of the face, lips or tongue, and/or shock (Anderson, 
2019).   
Other adverse reactions from the use of antibiotics include Stevens Johnson 
Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).  Stevens Johnson Syndrome 
and TEN are rare conditions but serious allergic reactions that result in severe skin, 
mucous membrane disorders, and death.  These reactions can occur with all antibiotics 
but are more commonly associated with sulfonamides, penicillin’s, cephalosporins, and 
fluoroquinolones (Anderson, 2019).  
 Another adverse condition of antibiotics is antibiotic resistance.  The Center for 
Disease Control (2020) and the World Health Organization (2018) report the rate of 
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antibiotic resistance as a world-wide epidemic.  The Center for Disease Control (2020) 
reported 2.8 million antibiotic resistant infections each year with 35,000 deaths.  In 
addition, the CDC reported 223,900 c-diff infections with 12,800 associated deaths each 
year.  The CDC and WHO correlated the antibiotic resistant infections and deaths with 
over prescribing of antibiotics, improper antibiotic medication administration and slow or 
inefficient bacterial testing.   
Antibiotic Resistance 
 Antibiotics are designed to fight and kill bacteria but some of them find new ways 
to survive.  They use resistant mechanisms to defend themselves against antibiotics by 
using instructions provided by their DNA.  Resistance genes are found within plasmids, 
small pieces of DNA that carry genetic instructions, and are shared to make themselves 
resistant (CDC, 2020).  
There are multiple ways bacteria become resistant.  They can restrict access of the 
antibiotic, get rid of antibiotics, change or destroy antibiotics, bypass the effects of 
antibiotics or change the targets for antibiotics.  An example is certain bacteria can 
change their outer membrane to keep antibiotic drugs from entering the cell.  
Pseudomonas aeruginosa bacteria generate pumps to get rid of the antibiotic and 
klebsiella pneumoniae bacteria can produce enzymes called carbapenemases, which 
break down carbapenem drugs and most other beta-lactam drugs (CDC, 2020). 
 The CDC (2019) recommends more specific testing to diagnose bacteria.  Specific 
testing allows the specific bacteria infecting a human to be grown in culture and tested 
against specific antibiotics.  The testing enables the prescriber to know what antibiotic is 
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best against that specific bacteria.  Another recommendation is longer treatment periods 
with specific antibiotics to treat bacteria that are resistant to broad spectrum antibiotics. 
Research has discovered that a subset of healthy bacteria could prevent 
colonization against antibiotic resistant bacteria (Pamer, 2016). Antibiotic treatment can 
damage normal gut bacteria, which could increase susceptibility to infections. 
Reestablishing normal gut bacteria after antibiotic treatment could help reduce infections.  
The research is still in the discovery phase but is an example of developing therapies to 
prevent resistant infections.  
  Martínez and Baquero (2014) found that there is an emergence of antibiotic 
resistance and is a relevant problem for human health.  Antibiotics cause bacterial growth 
inhibition by efficiently interacting with its target.  There are two ways this occurs: the 
antibiotic recognizes the bacterial target and there is enough antibiotic to cause inhibition 
of the bacterial activity.  The way antibiotics become resistant is when the bacteria 
modify their targets or there is a reduction of antibiotics that can access the bacteria 
(Martinez & Baquero, 2014).   
 Ventola (2015) found multiple causes for AMR including overuse, inappropriate 
prescribing, extensive agricultural use, availability of few, newer antibiotics and 
regulatory barriers.  In 2014, The Intercontinental Medical Statistics (IMS) Health Midas 
database estimated antibiotic consumption based on the volume of antibiotics sold to be 
22.0 standard units (standard units meaning one dose, pill, capsule, or ampoule) of 
antibiotics prescribed per person in the U.S.  It found 30% to 50% of all antibiotics 
prescribed were incorrect due to the wrong treatment indication, choice of antibiotic or 
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duration of use (Van Boeckel et al., 2014).  The antibiotics sold to farmers of livestock in 
the U.S. accounts for 80% of all antibiotics sold.  These animals lose healthy bacteria in 
the gut leading to overgrowth of resistant bad bacteria and is transferred to humans with 
consumption.  Finally, the regulatory barriers to develop new antibiotics and low cost of 
selling them make it difficult and not profitable for drug companies to even attempt 
creating such products.   
Resistant Antimicrobials 
 AMR is now considered one of the greatest threats to human health worldwide.  
The CDC (2018) reported Methicillin-resistant Staphylococcus aureus (MRSA) kills 
more Americans every year than emphysema, HIV/AIDS, Parkinson’s disease and 
homicide combined.  The CDC posted a weekly report that stated MRSA is a major cause 
of infection, from superficial to invasive infection, sepsis and death (Kourtis et al., 2019).  
It does point out that progress has been made in preventing infection but evidence 
suggests that the declining rate has slowed.  In 2017, an estimated 119,247 S. aureus 
bloodstream infections with 19,832 associated deaths. 
Tuberculosis (TB) is now linked to AMR strains and antibiotics that have been 
effective against TB are now insufficient.  The American Lung Association (2020), 
explains that TB can occur after inhaling Mycobacterium tuberculosis (M. tuberculosis) 
bacteria from a person with active TB and the bacteria can destroy the lung tissue.  The 
WHO (2019) states that only half of multidrug resistant TB is treated effectively.  Other 
infections are resistant to previously effective antibiotics because the antibiotics are used 
frequently or inappropriately.  There is a lack of research and development into new 
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antibiotic development because preexisting antibiotics have already been developed to 
cure infections and new antibiotics are considered unnecessary (WHO, 2019).   
The WHO (2019) stated antibiotics resistance is not a problem just in 
underdeveloped countries but worldwide.  Common community acquired bacterial 
infections including TB, gonorrhea, typhoid fever and Group B streptococcus have been 
noted as becoming AMR.  Community-acquired AMR is more concerning because of the 
ease of transmission.  These infections are usually transferred to patients that are already 
susceptible to other infections.     
 Strategies to Fight Antibiotic Resistance  
 Since the emergence of the AMR epidemic in 2013, the CDC released the first 
report, Antimicrobial Resistance Threats Report, about harm to human health posed by 
antibiotic resistance, which prompted government and industry leaders to take action.  
The report described the danger of antibiotic resistance and stated that each year in the 
U.S. at least 2 million people get an antibiotic-resistant infection and at least 35,000 
people die from AMR.  In 2014, the President’s Council of Advisors on Science and 
Technology (PCAST) released a report to combat AMR.  The report included sections for 
federal investment and leadership, monitoring antibiotic resistance, new antibiotics, 
stewardship of current antibiotics for humans/animal agriculture and international 
cooperation.  The report showed that current antibiotic stewardship programs are not 
sufficient throughout the United States and in only 50 percent of hospitals.  It further 
discussed the need to expand the steward programs into outpatient settings (CDC, 2013). 
11 
 
The president issued Executive Order 13676, which directed federal agencies to 
implement the recommendations in the PCAST.  In 2015, the White House hosted the 
Forum on Antibiotic Stewardship and released a five-year national action plan, outlining 
steps for implementing the national strategy to combat antibiotic resistance.  The same 
year congress appropriated funds to support the National Action Plan.  In 2016, the U.S. 
government participated in the United Nations (UN) General Assembly High-Level 
Meeting on Antimicrobial Resistance, where nations passed a resolution to combat 
antibiotic resistance worldwide.  In 2017, the U.S. President issued an executive order to 
continue advisory committees that showed commitment to combating antibiotic 
resistance.  Finally, in 2018, the U.S. government participated in the UN General 
Assembly High-Level Meeting, which covered antibiotic resistance and launched the 
Antimicrobial Resistance Challenge (ARC).  ARC is a year-long campaign by CDC that 
encourages global organizations to commit further progress against resistance (CDC, 
2019). 
 The WHO (2019) states that there needs to be coordinated action to fight against 
antimicrobial resistance.  AMR is a complex problem that affects all of society.  All 
countries need national action plans and greater innovations and investments to research 
and the development of antibiotics, vaccines and diagnostic tools.  The WHO 
recommends a Global Antibiotic Research and Development Partnership (GARDP), 
which is a joint initiative that encourages research and development through public-
private partnerships.  They hope to develop new antibiotic treatments by 2023.  They also 
propose the “Interagency Coordination Group on Antimicrobial Resistance” (IACG), 
which will coordinate between nations a sharing of antimicrobial knowledge.  The final   
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recommendation is for the implementation of antimicrobial stewardship programs (ASP) 
to help combat the already existent problems with overprescribing and incorrectly 
prescribed antibiotics.   
Antimicrobial Stewardship Program 
 The CDC and WHO both recognize the importance of antibiotic resistance 
in overall health.  Both of these organizations have multiple strategies to help combat the 
antibiotic resistance world-wide epidemic and it primarily starts with the use of 
antimicrobial stewardship programs.  Stewardship programs have multiple strategies in 
fighting against the persistent antibiotic resistant crisis that is currently happening (CDC, 
2019).   
 The CDC (2019) identifies core elements to an antibiotic stewardship program.  
The elements start with leadership commitment to dedicating staff, technology and 
resources.  An appointed leader who is responsible for the program outcomes is key.  
Drug expertise is needed hence an appointed pharmacist leader is a valuable member to 
improve antibiotic use. 
 An article by MacDougall (2005), explains that ASPs in inpatient settings vary 
and can include antibiotic policies, antibiotic management programs, antibiotic control 
programs, and other terms.  In general, they discuss what type of oversight is used at a 
healthcare institution to help with antibiotic resistance rates.  The programs may allow for  
substitution of antimicrobials in the same class for cost-saving purposes, switch  
intravenous-to-oral for highly bioavailable drugs, and pharmacokinetic consultation 
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services that impact antimicrobial use.  The CDC (2019) showed that since 2013, these 
ASPs have reduced the total AMR 18% overall and 30% in hospital settings.  
 The ASPs may include infectious diseases physicians, pharmacists, 
microbiologists, infection control staff, hospital epidemiologists and hospital 
administrators.  The team can implement and design how the AMS program functions. 
The team ensures therapeutic guidelines, antimicrobial restriction policies, or other 
measures are based on the best evidence available with low risk to patients.  ASPs use 
education techniques to try and reduce the amounts of antibiotics prescribed.  Lee et al. 
(2015) conducted a systematic review that concluded it is important to develop effective 
educational programs to reduce antibiotic use.  The findings support the importance of 
not only educating prescribers but also to include other medical professionals and the 
public.   
Outpatient Antibiotics and Education 
 According to The Pews Report (2016), approximately 13% (154 million visits 
annually) of all outpatient office visits in the United States result in an antibiotic 
prescription and 30% (47 million prescriptions) are unnecessary.  Outpatient antibiotics 
prescribed for patients with acute respiratory conditions (sinus infections, middle ear 
infections, pharyngitis, viral upper respiratory infections, bronchitis, asthma, allergies, 
influenza, and pneumonia) accounts for 44% of all prescriptions.  Half of these 




 Feller (2019) published a commentary on the Rhode Island Medical Society 
webpage titled “Why do doctors overprescribe antibiotic?” which explains multiple 
reasons for overprescribing.  It shows that antibiotics are ordered for disorders not caused 
by bacteria, bacterial culture results that were contaminated, broad-spectrum antibiotics 
over narrow spectrum, duration longer than required, wrong doses and antibiotics before 
culture results or without diagnostic testing.  Then it further explains that these decisions 
to prescribe are made because of cognitive influences.  For physicians they might believe 
antibiotics are “risk free”, undervalue long term risks, have a fear of malpractice, lack of 
physicians’ diagnostic skills and writing a prescription rather than explaining why it is 
not needed.  Patients may be influenced by media which may mislead them into a need 
for antibiotics and fear of “infections”.  Patients and physicians more easily recall 
someone “cured” with antibiotics and do not understand the antibiotic resistance.  Finally 
there is a patient-centered care movement which means patients are more likely to 
request or demand medications. 
. The CDC (2019) has posted guidelines, “The Core Elements of Outpatient 
Antimicrobial Stewardship” which reviews the fundamental elements of the program.  
The four core elements of outpatient antibiotic stewardship listed are commitment, action 
for policy and practice, tracking and reporting, and education and expertise.  The 
guidelines explain each of the elements and encourages outpatient settings to commit to 
at least one policy to improve antibiotic prescribing.  This offers outpatient settings with 
educational resources to patients and families on appropriate antibiotic use and clinicians 
with education aimed at improving antibiotic prescribing.  This also provides clinicians 
with access to experts in established antibiotic stewardship.  The program is not 
15 
 
mandatory for outpatient providers, however the individual providers have to accept these 
programs before it can be implemented.  It is a call to action for outpatient centers to join 
in the fight against antibiotic resistance.  Will antibiotic educational programs be 


















The theoretical framework used for this systematic review was the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).  The PRISMA 
Statement was created to improve the reporting of systematic reviews and meta-analyses. 
PRISMA can also be used for reporting systematic reviews of other types of research, 
particularly evaluations of interventions.  PRISMA is useful for critical appraisal of 
published systematic reviews (Moher, Liberati, Tetzlaff, Altman, The PRISMA Group, 
2009).  
PRISMA statement consists of a 27-item checklist (Appendix A) and four-phase 
flow diagram (Appendix B).  The checklist is divided into seven sections including title, 
abstract, introduction, methods, results, discussion, and funding.  Each of these sections 
have criteria listed to complete each section.  It summarizes all of the results from 
multiple studies into a single document.   
A four-phase flow diagram (Appendix B) shows the flow of information through 
the different phases of searching for randomized control trials and maps out the number 
of records identified, included and excluded, and the reasons for exclusions (Moher et al., 
2009).  Identification finds research studies within online databases and uses search terms 
in different combinations. This allowed the following terms to be utilized:  Antimicrobial 
Stewardships Programs, prescribing, education, bacteria, antibiotics, reduce antibiotic, 
outpatient, primary care and randomized control trial.  The results were checked to 
eliminate duplicate studies and appropriateness for research articles that applied to the 
research question.  Then eligibility of the studies left were checked to see if they met 
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specific inclusion and exclusion criteria.  Inclusion criteria were outpatient settings, 
antibiotic teaching, and studies within the last 10 years.  Exclusion criteria consisted of 
inpatient settings and only new educational programs for antibiotic prescribing.  Finally, 






















Purpose/Clinical Question/Outcomes Examined 
 The purpose of this systematic review was to determine if educational programs  
help to combat the world-wide epidemic of AMR in an outpatient setting.  The clinical 
question is to examine the effectiveness of antibiotic educational programs in outpatient 
settings at reducing antibiotic prescribing?  The articles were reviewed to see if 
educational programs helped to lower the amount of antibiotics used in outpatient settings 
without causing harm to patients. 
Inclusion/Exclusion Criteria/Limits 
 The systematic review included studies involving patients in outpatient settings 
that require antibiotics.  Inclusion criteria included randomized control trials that 
reviewed the rates of antibiotic prescribing in outpatient settings while using an 
educational program for recommended antibiotic prescribing and teaching for healthcare 
staff and patients.  Exclusion criteria included any randomized control trials that are older 
than ten years, patients that are hospitalized or in long term care facilities.   
Procedure  
 A literature search was conducted utilizing the search engines MEDLINE, 
PubMed, Google Scholar and CINHAL.  The search criteria included Antimicrobial 
Stewardships Programs, prescribing, education, bacteria, antibiotics, reduce antibiotic, 
outpatient, primary care and randomized control trial. A total of five articles were 
identified for the systematic review. 
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 Using the PRISMA four-phase diagram (Appendix A), 337 studies were 
identified and after being screened for duplicates, 117 articles were left.  The 117 articles 
were screened for eligibility and 80 were excluded.  The majority of articles were 
excluded for they were not specific to the outpatient setting.  The remaining 37 full text 
studies were further assessed for eligibility, which resulted in 5 appropriate randomized 
control trials.  The PRISMA four-phase diagram helped determine these articles were 
appropriate for this systematic review (Moher et al., 2009). 
Data collection.  The data was organized in a collection table (Appendix C). The 
data collected included the title of study, author(s), and type of randomized control trial.  
The aim/purpose and design for the study was listed as well as the sample of patients and 
providers.  Finally the method of education was listed and the outcomes after receiving 
antibiotic education.  
Table 1. (Appendix C) 
 
Critical appraisal. The data was appraised using the Critical Appraisal Skills 
Program (CASP) checklist.  The CASP has 11 questions to evaluate the randomized 





















systematic review.  The check list of questions determined the validity and conception of 
results and if they can be applied to the population chosen (Casp UK, 2013).  A checklist 
was done for each of the five articles chosen (Appendix D).  
Cross-study analysis.  A cross-study analysis compared the different randomized 
control trials included in the systematic review.  Using the cross-study analysis helped to 
summarize if educational programs reduced the amount of prescribed antibiotics in an 
outpatient setting.  Each study was listed with the type of educational intervention used 
and the outcomes of antibiotic prescribing after the intervention (Appendix E). 
Table 2. (Appendix E) 
Study Intervention Outcomes 













 The Prisma four-phase flow diagram (Appendix A) guided the process of 
identifying five randomized control trials. The PRISMA 27 item checklist (Appendix B) 
was used to identify the randomized control trials used for this systematic review.  A data 
table (Appendix C) organized the findings of each randomized control trials based on the 
purpose, design, sample, methods and outcomes.  The randomized control trials were 
assessed from the Critical Appraisal Skills Programme (CASP), a randomized control 
trial checklist (Appendix D).  Lastly, the studies were summarized in a cross study 
analysis to compare the outcomes across the studies (Appendix E). 
Individual Study Results 
 The randomized control trial completed by Butler et al. (2012) evaluated the 
effectiveness and cost of a multifaceted flexible educational program that was aimed at 
reducing antibiotic dispensing in primary care.  The article describes the online training 
program STAR: Stemming the Tide of Antibiotic Resistance.  This program includes 
case studies, provider reflection on prescribing antibiotics, choice of antibiotics, non-
medical factors that influence prescribing decision and patient communication.  It 
reinforces healthcare providers concepts of AMR and reflects when to prescribe 
antibiotics. 
The sample from Butler et al. (2012) was comprised of 68 general practices with 
an estimated 480,000 patients in Wales, United Kingdom.  Thirty-four practices were 
randomized to receive the education program and 34 practices to be the control with no 
education program.  Dynamic block allocation was used to achieve balance between 
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groups of practices for rate of antibiotic dispensing, practice size, and proportion of 
clinicians.  Practices were then divided into three arms with 24, 22 and 22 practices in 
each arm.  Each arm was then divided into an intervention group or control group.  The 
outcomes measured the number of antibiotics prescribed for all causes per 1000 patients 
in a year compared to previous year in the intervention group.  They also compared the 
rate of prescribed antibiotics for all causes per 1000 patients in a year compared to the 
previous year in the control group.  Finally both the intervention group and the control 
group were compared to each other. 
 The results from Butler et al. (2012) showed the rate of antibiotic prescriptions 
per 1000 patients decreased by 14.1 per 1000 patients in the intervention group and an 
increase of 12.1 per 1000 patients in the control group showing a net difference of 26.2 
per 1000 patients.  After adjustments for baseline dispensing a 4.2 percent reduction in 
oral antibiotic dispensing was found for the year relative to the control group (P = 0.02). 
The reduction of antibiotic prescribing was found in all classes of antibiotics except for 
with penicillinase-resistant penicillin. The largest prescription reduction was associated 
with phenoxymethylpenicillins (penicillin V) and macrolides.  There was no evidence 
that the intervention prevented hospital admissions or inpatient revisits for respiratory 
tract infections.   
 The Butler et al. (2012) study showed that the learning approach used for 
education for clinicians was effective in reducing the amount of antibiotic prescribing.  
Using the Critical Appraisal Skills Program (CASP) randomized controlled trials 
checklist, it showed the results of the trial as valid except the participants were not blind 
to the study.  The results apply to the context of this systematic review and the outcomes 
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were considered.  The benefits were worth the costs as it showed no harm to any of the 
participants.   
 The cluster randomized trial by Gerber et al. (2013) evaluated the effect of 
outpatient antimicrobial stewardship interventions on antibiotic prescribing for pediatric 
outpatients.  The trial was set up by block-randomized practices (clusters) by location and 
volume.  The unit of observation was the provider but randomized at practice level to 
avoid intra-practice contamination of the intervention.  A network of 25 pediatric primary 
care practices in Pennsylvania and New Jersey were chosen and 18 practices participated 
including 162 clinicians.   
The intervention from Gerber et al. (2013) was a one-hour on-site clinician 
education session followed by personalized, quarterly/audit feedback on prescribing for 
bacterial and viral acute respiratory tract infections (ARTIs).  Broad spectrum antibiotic 
prescribing for bacterial and viral ARTIs were compared for one year after the 
intervention in the intervention group and control. 
 The Gerber et al. (2013) study obtained electronic health records used by all 
practice sites for charting and prescribing from office and telephone encounters.  The 
results showed that broad spectrum antibiotic prescribing decreased from 26.8% to 14.3% 
in the intervention practices and only 28.4% to 22.6% in the control practices (difference 
of difference [DOD], 6.7 percent; P = 0.01).  The study measured off guideline 
prescribing for children: off guideline prescribing for pneumonia decreased from 15.7% 
to 4.2% in the intervention group compared to 17.1% to 16.3% in the control group 
(DOD, 10.7 percent; P < .001), and prescribing related to acute sinusitis decreased from 
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38.9% to 18.8% in the intervention group compared to 40.0% to 33.9% in control group 
(DOD, 14.0 percent; P=.12) respectively.  The off guideline prescribing for streptococcal 
pharyngitis and viral infections was determined to be at baseline.   
 The results from Gerber et al. (2013) showed that clinician education and 
feedback improved adherence to prescribing guidelines for bacterial ARTIs.  There was 
no difference noted with prescribing for viral infections.  The results of this trial using 
CASP showed that these results were valid.  The difference between groups was 
significant considering the changes in trajectories of broad-spectrum prescribing before 
and during the intervention between the two groups of practices.  The results show that 
the antimicrobial stewardship education helped locally to lower the rate of unnecessary 
antibiotic prescribing and concluded the results can be generalized.  The article did not 
discuss if all of the participants were truly blind to the study.    
 The three-arm, cluster-randomized trial by Gonzales et al. (2013) compared the 
impact of two decision support strategies for antibiotic treatment of acute bronchitis.  
There were 33 primary care practices in central Pennsylvania chosen for the trial.  These  
practices consisted of 9 large practices (with 9,000 to 15,000 annual patient visits) that 
were randomly assigned to each study arm.  The remaining 23 smaller practices (with 
2,000 to 9,000 annual visits) were also randomly assigned to each study arm.  Eleven 
practices received printed decision support (PDS) for acute cough illness, 11 other 
practices received electronic medical record-based decision support (CDS) and 11 
practices comprised the control group.   
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Gonzales et al. (2013) provided the PDS printed information for patients when 
they had a chief complaint of “cough”.  An informational poster on common causes of 
cough and treatments was placed in the exam room.  The CDS sites were alerted to “best 
practice alert” when chief complaint of cough was entered into the electronic health 
record.  The CDS sites had an electronic alert and “Smart Set” utilization when captured 
at the patient record level while inputting symptoms.  The “Smart Set” would create order 
sets for relevant testing and treatment options for bronchitis, pneumonia, sinusitis, URI 
and influenza.  Then a template was provided to include documenting relevant history 
and physical exam findings for patients with acute respiratory infections (ARI).  This data 
helped to categorize the probability of pneumonia and groups of electronic order sets 
were created to simplify testing and treatment options for bronchitis, pneumonia, 
sinusitis, ARI, and influenza.  Both groups received clinician education and feedback on 
prescribing practices and patient education brochures.  Antibiotic prescription rates for 
uncomplicated acute bronchitis for the winter of 2009-2010 were compared with the 
previous 3 winter periods. 
 Gonzales et al. (2013) showed the PDS group antibiotic prescribing decreased 
from 80.0% to 68.3%. The CDS group antibiotic prescribing decreased from 74% to 
60.7%.  The control group increased slightly from 72.5% to 74.3%.  The differences for 
the intervention groups were significant from the control (control vs. PDS P = 0.003; 
control vs. CDS P = 0.014). The change was not significant between the two intervention 
groups (PDS vs. CDS P = 0.67).  However, one-third of all providers reduced their 
antibiotic prescribing by over 20% in both intervention groups.   
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 The CASP showed that results of the Gonzales et al. (2013) trial were valid.  It 
wasn’t clear if the groups were blind to the study as all of the primary care practices 
belonged to an integrated health care system and from the same area.  The outcomes of 
implementing strategies for clinical algorithm-based decision support for acute cough 
were equally effective with printed and computer-assisted approaches.  These results can 
be applied to this research and all outcomes were considered.  The study showed no 
significant differences in the return rate of patient visits after the intervention, suggesting 
the decrease in antibiotic treatments were not associated with adverse effects.    
 The randomized control trial by McNulty et al. (2018) studied whether local 
trainer-led TARGET antibiotic workshops would improve the rate of antibiotic 
prescribing in general practices.  The trial used the McNulty-Zelen cluster randomized 
control trial design, which conceals from educational participants that they are in a trial.  
The trial obtains consent from a trusted third party to give consent on participants' behalf, 
then intervention practice staff choose whether to attend the offered education. The study 
used the McNulty-Zelen-design randomized controlled trial within three regions of 
England, 152 general practices were stratified by clinical commissioning group, antibiotic 
dispensing rate and practice patient list size.  The practices were randomly allocated and 
73 practices were offered the TARGET intervention.   
TARGET workshops in the McNulty et al. (2018) trial included a presentation, 
antibiotic reflective data, providing staff and patient resources, clinical scenarios and 
action planning.  The program included TARGET leaflets that are patient-focused and 
include information about self-care, expected illness duration and when to reconsult a 
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physician.  These patient-focused teaching pamphlets explain the need for antibiotics and 
help the provider with delayed prescribing of antibiotics to their patients.   
 The McNulty et al. (2018) study had 36 practices (51%) that accepted TARGET 
workshop invitation and 79 control practices.  There was an intent-to-treat (ITT) analysis 
done that showed a 2.7% lower rate of total antibiotic prescribing in the intervention 
practices compared to the control group (P = 0.06).  These rates include 4.4% lower 
prescribing of amoxicillin/ampicillin (P = 0.02) and 5.6% lower for trimethoprim (P = 
0.03) and a non-significant 7.1% higher rate for nitrofurantoin compared to the control 
group (P = 0.06).  
The CASP shows that the results of the McNulty et al. study were valid.  After the 
McNulty et al. (2018) trial, the Complier Average Casual Effect (CACE) analysis showed 
that there was a 6.1% lower antibiotic prescribing rate and 11% trimethoprim prescribing 
in the intervention with TARGET practices compared to the control.  The use of 
TARGET workshops including the freely available resources reduced the rate of 
antibiotic prescribing in primary care.  The trial shows education benefits this research 
with no evidence of harm to the patients.  
 The Legare et al. (2010) trial showed that involvement of patients leads to shared 
decision making (SDM) during the visit.  This would also provide optimal decisions by 
the FPs and patient that would translate into optimal prescribing.  The two-arm parallel 
clustered pilot randomized control trial was used to develop, adapt, and validate 
DECISION+ and estimate its impact on antibiotic use by family physicians (FPs) and 
their patients for acute respiratory infections (ARI).  DECISION+ protocol educates FPs 
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about probability of bacterial versus viral ARI with benefits and risks associated with 
each option.  It provided strategies to communicate with the patient and how to involve 
patients in the decision making of antibiotics use.  A biostatistician simultaneously 
randomized four family medicine groups (FMGs) to the immediate DECISION+ 
experimental group and the delayed DECISION+ control group.  From the 4 FMGs, there 
were 33 FPs and 459 patients that participated (FMGs = 2, FPs = 18, patients = 245) and 
the control group (FMGs = 2, FPs = 15, patients = 214).  The experimental group had 
received peer training sessions and workshops that the control group did not when 
initiating the DECISION+ program.   
   The CASP shows valid results for this trial and for experimental group, 21% 
fewer patients decided to use antibiotics immediately compared to the 8% in the control 
group (P = 0.08).  Out of the 33 FPs, three (9%) dropped out of the Legare et al. (2010) 
trial with no reasons explained.  The experimental group had 20 patients (8%) drop out of 
the trial and 14 patients (5%) from the control group because they did not follow up in 
two weeks.  It was also unclear if the study was a true blind study as the FPs in the 
control group could have looked up DECISION+ information.  The study found 
education for providers and patients contribute to the reduction of antibiotic prescribing.  
The DECISION+ program lowers the antibiotics for ARIs without adverse patient 
outcomes.   
Cross-Study Analysis  
 All five of the randomized control trials found that educational programs 
reduced the overall prescribing of antibiotics.  Butler et al. (2012) used the Stemming the 
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Tide of Antibiotic Resistance (STAR) educational program and showed a rate of oral 
antibiotic dispensing decreased by 14.1 per 1000 in the intervention group and increased 
by 12.1 per 1000 in the control group for a net difference of 26.1 per 1000.  The Gerber et 
al. (2013) used clinician education coupled with audit and feedback of an antibiotic 
prescribing to children with ARTIs.  This showed a broad-spectrum antibiotic prescribing 
decreased from 26.8% to 14.3% among intervention practices and only 28.4% to 22.6% 
in the control.  Off-guideline prescribing for children with pneumonia decreased from 
15.7% to 4.2% among intervention practices and 39.8% to 18.8% for acute.   
Gonzales et al. (2013) used two intervention groups with printed decision support 
(PDS), a computer decision support (CDS) and a control group.  PDS group antibiotic 
prescribing decreased from 80.0% to 68.3%, CDS group decreased from 74% to 60.7%  
and the control group increased slightly from 72.5% to 74.3% for prescribed antibiotics 
for acute cough illnesses.  It was also found that one third of the providers in intervention 
groups reduced prescribing antibiotics all together by 20%.  The McNulty et al. (2018) 
study had intervention participants that complete a TARGET workshop.  This study 
showed a 6.1% lower antibiotic prescribing rate and 11% lower trimethoprim prescribing 
in the intervention with TARGET practices compared to the control.  Finally Légaré et al. 
(2010) used DECISION+ and showed 21% fewer patients decided to use antibiotics 
immediately and the control group only 8% fewer patients decided to use antibiotics.  
Percentage of patients who decided to use antibiotics after consultation was 52.2% in the 
control group and 27.2% in the experimental group.   
Not all clinicians in each practice had participated so studies that would analyze 
data from practices where all clinicians participated could increase potential practice 
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effects on antibiotics.  The studies also do not include patients’ perceptions of antibiotics, 

























Summary and Conclusions 
 The CDC and WHO have determined that AMR is a growing epidemic that needs 
further investigation and research to lower the rates of resistance.  According to the 
Center for Disease Control and Prevention (CDC, 2020), the United States has over 
35,000 deaths and over 2 million illnesses per year due to antibiotic resistance (WHO, 
2020).  The WHO and CDC acknowledge the need for stricter regulations on antibiotic 
prescribing.   
Both organizations found implementation of ASPs helps fight the epidemic of 
antibiotic resistance in inpatient setting.  One key aspect of ASPs effort to reduce AMR is 
the creation of educational tools for providers to enhance appropriate antibiotic 
prescribing practices (WHO, 2018).  The purpose of this systematic review is to examine 
the effectiveness of antibiotic educational programs in an outpatient setting. 
To research this a search of current randomized control trials from the past ten 
years was done using MEDLINE, PubMed, Google Scholar and CINHAL.  The search 
criteria included antimicrobial stewardship programs, outpatient, bacteria, antibiotics, 
primary care and randomized control trial.  Using the Prisma 4-phase flow diagram 
(Appendix A) (Moher, 2009), 5 randomized control trials were selected with the 
assistance of the   PRISMA 27 item checklist (Appendix B).   
The data from each of the randomized control trials was organized into a data 
table (Appendix C).  The purpose, design, sample, methods and outcomes of the studies 
where listed.  The Critical Appraisal Skill Program (CASP) was used to critically 
appraise the different types of evidence in each study.  Finally, a cross study analysis data 
table (Appendix E) was utilized with each studies name, interventions and outcomes. The 
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studies were categorized with the name of the study, the interventions used and the 
outcomes of the study. 
All of the studies included show that when antibiotic education is provided in an 
outpatient setting, providers reduce their rates of antibiotic prescribing.  These studies 
show that with education and training in an outpatient setting, lower prescribed 
antibiotics can be achieved.  They also focused on outpatient prescribing and teaching to 
reduce the amount of prescribed antibiotics for unnecessary illness.   
The CDC points out four ways to reduce AMR and these studies focused on the 
appropriate use of antibiotics (CDC, 2019).  There is still a need for better lab diagnostics 
to improve antibiotic prescribing, sharing of data and better infection control measures.  
Studies could compare data about diagnostic machines to see which ones were more 
accurately testing specimens.  The outpatient settings could determine if sharing of data 
amongst each other would help to lower antibiotic prescribing rates.  Studies could also 
compare rates of bacterial infections to seasons or by age group to see if each practice is 
prescribing at the same rates as others.   
The World Health Organization (WHO, 2018) also acknowledges the need for 
stricter regulations on antibiotic prescribing.  The ASPs have already been established in 
the inpatient setting and they have in-house pharmacist, infectious disease consults, and 
computer algorithms that help antibiotic prescribing.  Currently outpatient settings are not 
all electronically linked so it makes it more difficult to use the ASPs found in electronic 
algorithms.  Studies could be performed at the pharmacy level to see if they could track 
providers and amounts of antibiotic being prescribed by individual providers.  The 
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pharmacists could also require confirmed laboratory data before filling antibiotic 
prescriptions.   
The educational tools being developed and studied appear to lower the amounts of 
antibiotics prescribed.  This systematic review shows that outpatient antibiotic 
educational programs are effective.  These educational programs effectively help 
continue to lower the amount of antibiotic resistance the world faces today but further 















Recommendations and Implications for Advanced Nursing Practice 
 The CDC and WHO have clearly provided data that antibiotic resistance is a 
worldwide issue that needs to be addressed.  The evidence is supported by both 
organizations and multiple recommendations to help with resistance are suggested 
including utilizing educational programs for providers and patients.  Educational 
programs have developed training tools, teaching seminars, chart reviews, evidence-
based practice prescribing recommendations, patient teaching, and joint patient/provider 
decision making.     
 The five studies included in this systematic review all showed that implementing 
the education programs helped to lower the amount of prescribed antibiotics without 
adverse effects to the patient.  These studies prove to the advanced practice registered 
nurse (APRN) that education plays a key role in decision making about prescribing.  
Some of the studies included the patients in decision making which helped  providers to 
not prescribe antibiotics, without patient satisfaction being compromised.   
 The role of an APRN includes research and education to help all APRNs in 
following evidence-based practice in the field.  An article by Harbman et al. (2016) states 
that health care administrators are seeking new ways to utilize all dimensions of APRN 
expertise, especially related to research and evidence based practice.  The article showed 
that international studies reveal research as the most underdeveloped and underutilized 
aspect of these roles.  The APRNs should be utilized in conducting point of care research, 
quality improvement and evidence based practice projects.  This helps healthcare systems 
to improve patient, provider, and system outcomes which benefits everyone.   
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 An article by Lamb et al. (2018) was aimed at describing the leadership 
capabilities of advanced practice nurses.  It showed that the APRN should be considered 
in organization’s patient focused leadership and organization/system focused leadership.  
The article describes APRNs as leaders that can contribute to environmental 
improvements for patients, families, nurses, healthcare providers and the healthcare 
system.  With education and evidence-based practice/research being conducted by 
APRNs, they can help implement strategies to reduce the overprescribing of antibiotics.   
 The role of an APRN is not just limited to being a provider for patients.  All 
APRNs should consider themselves as providers that can research best practice and 
implement change in the healthcare systems that they work in.  If there is a lack of  
education or research, the APRN should recognize the need and try to implement it.  
Using current research and starting programs, like the educational programs discussed, is 






American Lung Association. (2020, May 1). Tuberculosis 
(TB).https://www.lung.org/lung-health-diseases/lung-disease-lookup/tuberculosis 
Aminov, R. I. (2010). A brief history of the antibiotic era: Lessons learned and challenges 
for the future. Frontiers in Microbiology. doi:10.3389/fmicb.2010.00134 
Anderson, L. (2019). Antibiotics - Common side effects, allergies and reactions. 
Retrieved from https://www.drugs.com/article/antibiotic-sideeffects-allergies-
reactions.html 
Butler, C. C., Simpson, S. A., Dunstan, F., Rollnick, S., Cohen, D., Gillespie, D., … 
 Hood, K. (2012). Effectiveness of multifaceted educational programme to reduce 
antibiotic dispensing in primary care: practice based randomised controlled trial. 
The British Medical Journal, 344(feb021), d8173–d8173. doi: 10.1136/bmj.d8173 
CASP checklists - CASP - Critical Appraisal Skills Programme. (2019, November 1). 
Retrieved from 
 https://casp-uk.net/casp-tools-checklists/ 
Centers for Disease Control and Prevention. (2020, March 13). Biggest threats and data.  
https://www.cdc.gov/drugresistance/biggest-threats.html 
Centers for Disease Control and Prevention. (2019, November 14). Core elements of 




Centers for Disease Control and Prevention (2019, December 1). U.S. national strategy 
for combating antibiotic-resistant bacteria (National Strategy). 
https://www.cdc.gov/drugresistance/us-activities/national strategy.html 
Etebu, E., & Arikekpar, I. (2016). Antibiotics: Classification and mechanisms of action 
 with emphasis on molecular perspectives. International Journal of Applied 
Microbiology and Biotechnology Research, 4, 90-101. Retrieved from        
https://pdfs.semanticscholar.org/aebc/840138529c147e54552205bf26ec8aa3ca2e.
pdf 
Feller, E. (2019, February). Why do doctors overprescribe antibiotics? Retrieved August 
29, 2020, from http://www.rimed.org/rimedicaljournal/2019/02/2019-02-09-
feller.pdf 
Gerber, J. S., Prasad, P. A., Fiks, A. G., Localio, A. R., Grundmeier, R. W., Bell, L. 
  M.,…Zaoutis, T. E. (2013). Effect of an outpatient antimicrobial stewardship 
  intervention on broad-spectrum antibiotic prescribing by primary care 
  pediatricians. Journal of the American Medical Association,  
  309(22), 2345-2352. doi:10.1001/jama.2013.6287 
Gonzales, R., Anderer, T., Mcculloch, C. E., Maselli, J. H., Bloom, F. J., Graf, T. R., … 
  Metlay, J. P. (2013). A cluster randomized trial of Decision support strategies for 
  reducing antibiotic use in acute bronchitis. Journal of the American Medical  
  Association Internal Medicine, 173(4), 267-263. doi: 
  10.1001/jamainternmed.2013.1589 
38 
 
Harbman P. (2014). The development and testing of a nurse practitioner secondary 
  prevention intervention for patients after acute myocardial infarction: a 
  prospective cohort study. International Journal of Nursing Studies,  
  51(12), 1542–1556. https://doi.org/10.1016/j.ijnurstu.2014.04.004 
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). How antibiotics kill bacteria: 
From targets to networks. Nature Reviews Microbiology, 8(6), 423-435. 
doi:10.1038/nrmicro2333 
Kourtis A.P., Hatfield K., Baggs J, et al. Vital signs: Epidemiology and recent trends in 
methicillin-resistant and in methicillin-susceptible Staphylococcus aureus 
bloodstream infections — United States. Morbidity and Mortality Weekly Report 
2019;68:214–219. DOI: http://dx.doi.org/10.15585/mmwr.mm6809e1 
Lamb, A., Martin-Misener, R., Bryant-Lukosius, D., & Latimer, M. (2018). Describing 
the leadership capabilities of advanced practice nurses using a qualitative 
descriptive study. Nursing Open, 5(3), 400–413. doi: 10.1002/nop2.150 
Lee, C.-R., Lee, J. H., Kang, L.-W., Jeong, B. C., & Lee, S. H. (2015). Educational 
effectiveness, target, and content for prudent antibiotic use. BioMed Research 
International, 2015, 1–13. doi: 10.1155/2015/214021 
Légaré F, Labrecque M, LeBlanc A, et al. Training family physicians in shared decision 
making for the use of antibiotics for acute respiratory infections: a pilot clustered 




MacDougall, C., & Polk, R. E. (2005). Antimicrobial stewardship programs in health 
care systems. Clinical Microbiology Reviews, 18(4), 638–656. 
https://doi.org/10.1128/CMR.18.4.638-656.2005 
Martínez, J. L., & Baquero, F. (2014). Emergence and spread of antibiotic resistance: 
Setting a parameter space. Upsala Journal of Medical Sciences, 119(2), 68-77. 
doi:10.3109/03009734.2014.901444 
McNulty, C., Hawking, M., Lecky, D., Jones, L., Owens, R., Charlett, A., … Francis, N. 
(2018). Effects of primary care antimicrobial stewardship outreach on antibiotic 
use by general practice staff: pragmatic randomized controlled trial of the 
TARGET antibiotics workshop. Journal of Antimicrobial Chemotherapy, 73(5), 
1423–1432. doi: 10.1093/jac/dky004 
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA 
Statement. PLoS Med 6(7): e1000097. 
https://doi.org/10.1371/journal.pmed.1000097 
Pamer, E. G. (2016). Resurrecting the intestinal microbiota to combat antibiotic-resistant 
pathogens. Science, 352(6285), 535–538. doi: 10.1126/science.aad9382 






Van Boeckel, T., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B., Levin, S., & 
Laxminarayan, R. (2014, August). Global antibiotic consumption 2000 to 2010: 
An analysis of national pharmaceutical sales data. Retrieved April 14, 2020, from 
https://www.ncbi.nlm.nih.gov/pubmed/25022435 
Ventola C. L. (2015). The antibiotic resistance crisis: part 1: causes and threats. 
  Pharmacy and Therapeutics: a peer reviewed journal for formulary management, 
  40(4), 277–283.  
World Health Organization. (2020, May 28).   Drug-resistant tuberculosis.  
 https://www.who.int/tb/areas-of-work/drug-resistant-tb/en/ 
World Health Organization. (2018, November 12). Wide differences in antibiotic use 

















































Records identified through 
database searching 
























Additional records identified 
through other sources 
(n = 210) 
Records after duplicates removed 
(n = 117) 
Records screened 
(n = 117) 
Records excluded 
(n = 80) 
Full-text articles 
assessed for eligibility 
(n = 37) 
Full-text articles 
excluded, with reasons 
(n = 32) 
Studies included in qualitative 
synthesis 
(n = 5) 
Studies included in quantitative 
synthesis (meta-analysis) 



















Butler, C. C., Simpson, S. A., Dunstan, F., Rollnick, S., Cohen, D., Gillespie, D., … Hood, K. (2012). Effectiveness of multifaceted 
educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. British Medical 





























Randomized controlled trial 
with general practices to 
intervention or control. 
Patients can be managed by any of 
the providers in the practice so the 
practice was considered as the unit 
for randomization and analysis. 
 
Dynamic block allocation achieved 
balance between group of practices 
for rate of antibiotic dispensing, 
practice size and proportion of 
clinicians.  Practices then divided 
into three sets of 24, 22 and 22 
practices and each set allocated 
into two groups.  All blinded to 
group allocation until after 
randomization.  
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The rate of oral antibiotic dispensing 
decreased by 14.1 per 1000 in the 
intervention group, increased by 12.1 per 
1000 in the control group, a net 
difference of 26.2 per 1000.  
 
A 4.2% (95% confidence interval 0.6% 
to 7.7%) reduction in oral antibiotic 
dispensing for the year in the 
intervention group relative to the control 
group (P=0.02) 
  
No significant differences between 
intervention/control practices in the 
number of admissions to hospital, 
consultations for a respiratory tract 
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Cluster randomized trial  
by block-randomized 
practices (clusters) by 
location and volume.   The 
unit of observation was the 
provider but randomized at 
practice level to avoid 
intra-practice 
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practices using a common 






25 pediatric primary 
care practices  
 
Of 20 eligible 




9 randomized to 
intervention 
with 81 clinicians 
 
9 control groups 


















Broad-spectrum prescribing decreased from 
26.8% to 14.3% among intervention 
practices vs from 28.4% to 22.6%.  
 
Off-guideline prescribing for children with 
pneumonia decreased from 15.7% to 4.2% 
among intervention practices compared 
with 17.1% to 16.3% and for acute sinusitis 
from 39.8% to 18.8%.  
 
Off-guideline prescribing was uncommon 
at baseline and changed little for 
streptococcal pharyngitis (intervention 
from 4.4% to 3.4%; control from 5.6% to 
3.5%) and for viral infections (7.9% to 
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3-arm cluster randomized trial  
 
Paper decision strategy (PDS), 
computer decision strategy 
(CDS) arm and a control arm.  
 
One test site was used for the 
CDS development and 
assigned as a control site. The 
remaining practices, 9 large 
practices (with 9,000 to 15,000 
annual patient visits) were 
randomly assigned to each 
study arm, the remaining 23 
smaller practices (with 2,000 
to 9,000 annual visits) were 
















PDS intervention arm received 
decision support for acute cough 
illness through a print-based 
strategy  
 
CDS group received decision 
support through an electronic 
medical record-based strategy 
 
Control group of practices 
served as the control arm 
 
Intervention groups  received 
education and feedback on 
prescribing practices, and 
patient’s received education 




PDS group antibiotic 
prescribing decreased from 
80.0% to 68.3% of prescribed 
antibiotics for acute cough 
illness  
 
CDS group decreased from 
74% to 60.7%  
 
Control group increased 
slightly from 72.5% to 74.3%.  
 
1/3 providers in intervention 
groups reduced antibiotic 
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randomized controlled trial of 
152 general practices that were 
stratified by clinical 
commissioning group, antibiotic 
dispensing rate and practice 
patient list size.  Then 73 
practices were randomly 
allocated to be offered the 
intervention, TARGET 
workshop with a presentation, 
reflection on antibiotic data, 
promotion of patient and general 
practice (GP) staff resources, 













79 practices in 








completed TARGET AMS 
self-assessment and a one-
hour workshop including 
the TARGET PowerPoint 
presentation.  Advantages 
and evidence around 
benefits for or against 
antibiotics for common 
community infections 
using national PHE 
antibiotic and NICE 
guidance, clinical scenarios 




Initial antibiotic dispensing rate 
was 2.7% lower in the 
intervention practices compared 
to control group.   
 
4.4% lower prescribing of 
amoxicillin/ampicillin  
5.6% lower for trimethoprim and 
a non-significant  
7.1% higher rate for 
nitrofurantoin.  
 
The trial showed a 6.1% lower 
antibiotic prescribing rate and 
11% trimethoprim prescribing in 
the intervention with TARGET 
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AIM/PURPOSE 
 
To develop, adapt 
and validate 
DECISION+ and 
estimate its impact 
on decision of 
family physicians 
and their patients 

























randomized four family 
medicine groups to 
immediate DECISION+ 
participation (the 
experimentation of the 












2 FMGs with 18 
family practitioners 




2 FMGs with 15 
FPs and 214 







provided to FPs. 















months later.  
OUTCOMES 
 
In the experimental group, 21% fewer 
patients decided to use antibiotics 
immediately and the control group only 
8%. 
 
The percentage of patients who decided to 
use antibiotics after consultation was 
52.2% in the control group and 27.2% in 
the experimental group (absolute difference 
25.0%, adjusted relative risk 0.48, 95% 
confidence interval 0.34–0.68).  
 
DECISION+ was associated with patients 
taking a more active role in decision-
making and reported outcomes 2 weeks 
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Cross study analysis table 




Stemming the Tide of Antibiotic 
Resistance (STAR) educational 
program included a practice-
based seminar reflecting on the 
practices’ own dispensing and 
resistance data, online 
educational elements, and 
practicing consulting skills in 
routine care for the experimental 
group.  
Rate of oral antibiotic dispensing 
decreased by 14.1 per 1000 in the 
intervention group 
 
Increased by 12.1 per 1000 in the 
control group 
 





Clinician education coupled with 
audit and feedback of an 




prescribing decreased from 26.8% to 
14.3% among intervention practices 
vs from 28.4% to 22.6%.  
 
Off-guideline prescribing for 
children with pneumonia decreased 
from 15.7% to 4.2% among 
intervention practices compared 
with 17.1% to 16.3% and for acute 





PDS intervention arm received 
decision support for acute cough 
illness through a print-based 
strategy  
 
CDS group received decision 
support through an electronic 
medical record-based strategy 
 
Control group of practices 
served as the control arm 
 
Intervention groups also 
received education and feedback 
on prescribing practices, and 
patient education brochures at 
check-in.  
PDS group antibiotic prescribing 
decreased from 80.0% to 68.3% 
prescribed antibiotics for acute 
cough illnesses  
 
CDS group decreased from 74% to 
60.7%  
 
Control group increased slightly 
from 72.5% to 74.3%.  
 
The differences for intervention 
groups and control (control vs. PDS 
P=0.003; control vs. CDS P=0.014)  
One third providers in intervention 
groups reduced prescribing 20% 
 
Difference between intervention 
groups 







completed TARGET AMS self-
assessment and a one hour 
workshop including the 
TARGET PowerPoint 
presentation, stress the 
advantages to staff and patients 
of AMS, evidence around 
benefits for or against antibiotics 
for common community 
infections using national PHE 
antibiotic and NICE guidance, 
clinical scenarios and antibiotic 
prescribing monitoring 
6.1% lower antibiotic prescribing 
rate  
11% trimethoprim prescribing in the 
intervention with TARGET 




Primary outcome was the 
proportion of patients who 
decided to use antibiotics 
immediately after consultation 
with providers using 
DECISION+ and where shared 
decision-making had occurred. 
 
Control group providers were 
just given DECISION+ with no 
training or workshops. 
 
Experimental group showed 21% 
fewer patients decided to use 
antibiotics immediately 
 
Control group only 8% fewer 
patients decided to use antibiotics 
 
Percentage of patients who decided 
to use antibiotics after consultation 
was 52.2% in the control group and 
27.2% in the experimental group 
(absolute difference 25.0%, adjusted 
relative risk 0.48, 95% confidence 
interval 0.34–0.68).  
 
DECISION+ was associated with 
patients taking a more active role in 
decision-making (Z = 3.9, p < 
0.001). Patient outcomes 2 weeks 
after consultation were similar in 
both groups. 
 
 
 
 
 
